Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
SMI 10'221 0.9%  SPI 13'098 0.7%  Dow 29'684 1.9%  DAX 12'183 0.4%  Euro 0.9497 -0.2%  EStoxx50 3'335 0.2%  Gold 1'660 1.9%  Bitcoin 19'147 1.0%  Dollar 0.9756 -1.6%  Öl 89.3 4.2% 

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
18.08.2022 13:55:49

TPG weighing roughly $2 bln sale of diagnostics company Immucor: Report

TPG Inc. is considering the sale of portfolio company Immucor Inc., a Norcross, Ga.-based specialist in blood transfusion and transplantation diagnostics, according to a report Thursday by Bloomberg. The business is expected to draw a price of about $2 billion, with interest from other private equity firms as well as companies in related businesses, the report said. TPG took Immucor private in 2011 for $27 per share in cash or about $1.94 billion. Shares of TPG closed at $32.39 on Wednesday, up about 10% from its price of $29.50 on Jan. 11 in its initial public offering. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Weiter zum vollständigen Artikel bei "Market Watch"

INFLATION: WELTWEIT STEIGEN DIE PREISE

Viele Anleger setzen deshalb auf den Aktiv verwalteten Global Inflation Protection Basket. Informieren Sie sich über die breit gestreute Auswahl an robusten Aktien & ETFs.